Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation by Huck, K. et al.
Research article
1350	 The	Journal	of	Clinical	Investigation	 	 	 http://www.jci.org	 	 	 Volume 119	 	 	 Number 5	 	 	 May 2009
Girls homozygous for an IL-2–inducible  
T cell kinase mutation that leads to protein 
deficiency develop fatal EBV-associated 
lymphoproliferation
Kirsten Huck,1 Oliver Feyen,1 Tim Niehues,2 Franz Rüschendorf,3 Norbert Hübner,3  
Hans-Jürgen Laws,1 Tanja Telieps,1 Stefan Knapp,4 Hans-Heinrich Wacker,5 Alfons Meindl,6  
Hassan Jumaa,7 and Arndt Borkhardt1
1Department of Pediatric Oncology, Hematology and Clinical Immunology, Centre for Child and Adolescent Health, Heinrich Heine University, Düsseldorf, 
Germany. 2Centre for Child and Adolescent Health, HELIOS Klinikum Krefeld, Krefeld, Germany. 3Max Delbrück Center for Molecular Medicine (MDC), Berlin, 
Germany. 4Structural Genomics Consortium, Nuffield Department of Medicine, and Department of Clinical Pharmacology, University of Oxford, Headington, 
Oxford, United Kingdom. 5Joint Practice for Hematopathology, Kiel, Germany. 6Klinikum rechts der Isar, Technische Universität, Munich, Germany.  
7Department of Molecular Immunology, Max Planck Institute of Immunobiology, Freiburg, Germany.
The	fatal	immune	dysregulation	that	sometimes	follows	EBV	infection	in	boys	has	been	linked	to	mutations	
in	two	X	chromosome–encoded	genes,	SLAM-associated	protein	(SAP)	and	X-linked	inhibitor	of	apoptosis	
(XIAP).	In	this	study	we	describe	2	girls	from	a	consanguineous	Turkish	family	who	died	after	developing	
severe	immune	dysregulation	and	therapy-resistant	EBV-positive	B	cell	proliferation	following	EBV	infection.	
SNP	array–based	genome-wide	linkage	analysis	revealed	IL-2–inducible	T	cell	kinase	(ITK)	as	a	candidate	gene	
for	this	immunodeficiency	syndrome.	Both	girls	harbored	a	homozygous	missense	mutation	that	led	to	sub-
stitution	of	a	highly	conserved	residue	(R335W)	in	the	SH2	domain	of	ITK.	Characteristics	of	ITK	deficiency	
in	mouse	models,	such	as	absence	of	NKT	cells	and	high	levels	of	eomesodermin	in	CD8+	cells,	were	seen	in	
either	one	or	both	of	the	girls.	Two	lines	of	evidence	suggested	that	R335W	caused	instability	of	the	ITK	pro-
tein.	First,	in	silico	modeling	of	the	mutant	protein	predicted	destabilization	of	the	SH2	domain.	Additionally,	
Western	blot	analysis	revealed	that,	unlike	wild-type	ITK,	the	R335W	mutant	was	nearly	undetectable	when	
expressed	in	293	T	cells.	Our	results	suggest	that	ITK	deficiency	causes	what	we	believe	to	be	a	novel	immu-
nodeficiency	syndrome	that	leads	to	a	fatal	inadequate	immune	response	to	EBV.	Because	ITK	deficiency	
resembles	EBV-associated	lymphoproliferative	disorders	in	boys,	we	suggest	that	this	molecular	cause	should	
be	considered	during	diagnosis	and	treatment.
Introduction
Severe immune dysregulation in boys after primary infection 
with EBV, presenting as fatal mononucleosis, hemophagocyto-
sis, hypogammaglobulinemia, and lymphoproliferation, is the 
hallmark of X-linked lymphoproliferative disease (XLP), a well-
known inherited immunodeficiency disorder (1). Mutations in 
the SH2 domain protein 1A (SH2D1A), also referred to as sig-
naling lymphocytic activation molecule family member 1–associ-
ated (SLAM-associated) protein (SAP), account for approximately 
60% of XLP cases (2–4). In addition, mutations in the X-linked 
inhibitor of apoptosis (XIAP) protein have been shown to be caus-
ative in 3 XLP families (5). Recently, several studies have demon-
strated an almost complete absence of NKT cells in lymph nodes, 
liver, spleen, and thymus of SAP-deficient mice as well as in the 
blood of patients with XLP carrying mutations in SAP and XIAP 
(5–8). As the lack of NKT cells is a shared feature of SAP and XIAP 
deficiency, a critical role has been postulated for NKT cells in the 
response to EBV infection.
In addition to SAP and XIAP, the SLAM receptor family mem-
ber 1, the tyrosine kinase Fyn, and 2 members of the Tec family 
kinases, namely the resting lymphocyte kinase (RLK) and the IL-2– 
inducible T cell kinase (ITK), have been shown to be required for 
the development of NKT cells in mice (9–13).
We examined a consanguineous Turkish family in which 2 
girls died after showing a fatal EBV-associated lymphoprolifera-
tive disorder clinically resembling XLP. In both girls we found 
homozygous mutations in the SH2 domain of ITK. The identified 
mutation R335W results in protein destabilization, lack of ITK in 
lymph node biopsies, and absence of NKT cells. Thus, we believe 
ITK deficiency to be a novel primary immunodeficiency character-
ized by fatal immune dysregulation following EBV infection.
Results
Patients
Patient 1. The female index patient was the first child of healthy 
consanguineous Turkish parents. At the age of 5 years 2 months, 
immunoglobulin levels, measured during an episode of aph-
thous stomatitis and subsequent candida stomatitis, were nor-
mal. From the age of 6 years, she successively developed recurrent 
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episodes of fever and elevated C-reactive protein (CRP), nodu-
lar interstitial pulmonary infiltrates unresponsive to antibiotic 
treatment, generalized lymphadenopathy, hepatosplenomegaly 
with impaired liver function, pleural and pericardial effusion, 
anemia, thrombocytopenia, and hypogammaglobulinemia. EBV 
viral capsid antigen (VCA) IgG antibodies were positive in the 
absence of Epstein-Barr nuclear antigen 1 (EBNA1) and VCA IgM 
antibodies (Table 1). At the age of 6 years 10 months, she was 
transferred to our hospital. EBV PCR confirmed active EBV infec-
tion. The biopsy of an axillary lymph node showed polymorphic 
B cell proliferation. These cells were CD20+ (Figure 1A), CD22+, 
CD10–, and part of the population was CD30+. Focal expression 
of the EBV latent membrane protein 1 (LMP1) and 30% EBV-
encoded RNA reactivity in in situ hybridization demonstrated 
the relation to EBV infection. Staining for EBNA2 was negative 
(Table 1). Clonality analysis revealed oligoclonal amplification 
of the CDRIII immunoglobulin heavy-chain region (data not 
shown). BM aspirate was normal, with no evidence for lymphoma 
infiltration, histiocytosis, or hemophagocytosis.
Because the disease phenotype resembled X-linked lymphopro-
liferative disease mutations in SLAM (CD150), SAP, natural killer 
cell receptor 2B4 (2B4), TNFRSF6 (also known as FAS), and EAT 
were excluded. An extensive immunological work-up, results of 
which are described in Table 2, did not contribute to elucidating 
the underlying defect. The patient received 4 courses of the mono-
clonal CD20 antibody rituximab at weekly intervals in addition 
to foscavir and steroids, which led to a marked reduction of EBV 
load and resolution of the clinical symptoms. A flare with increas-
ing virus load and progressive intrapulmonary infiltrates at the 
age of 7 years 11 months was again responsive to rituximab. At 
the age of 8 years 2 months, a tumor of the right nasal concha was 
histologically identified as an EBV-associated Hodgkin lymphoma 
with strong expression of CD30 and LMP1, negative for CD15 and 
Ki-A10. CD20 negativity was attributed to the previous treatment 
with rituximab. The tumor was successfully treated according to 
a standard chemotherapy protocol using prednisone, procarba-
zine, vincristine, cyclophosphamide, and adriamycine followed by 
fractionated local and mediastinal irradiation. During the follow-
ing years, the disease progressed with increasing EBV loads up to 
3 × 107 copies/μg DNA and mainly cervical lymphadenopathy 
despite continued intensive treatment. We observed a continuous 
decline in lymphocytes, especially CD45RACD4+ T cells. At the 
age of 10 years 4 months, BK polyomavirus infection with high 
BK virus loads in urine and PB was diagnosed. At the same time, 
the girl acquired Pneumocystis jirovecii pneumonia and died from 
respiratory failure at the age of 10 years 5 months.
Patient 2. Patient 2 was the index patient’s younger sister. At the 
age of 16 months, immunological evaluation at our institution 
Table 1
Characteristics of EBV infection
Characteristic	 Patient	1	 Patient	2
Serology 
Anti–VCA IgG Positive PositiveA
Anti–VCA IgM	 Negative NegativeA
Anti–VCA IgA (U/ml)	 320 nd
Anti–EA IgG (U/ml)	 80 nd
Anti–EA IgA (U/ml)	 <20 nd
Anti–EBNA1 IgG	 Negative PositiveA
Initial	viral	load	(copies/μg	DNA)
Whole blood nd 5,280
Isolated NK cells nd 9 (during follow-up)
Isolated T cells nd 0 (during follow-up)
BM nd 33,7000
Expresion	of	EBV	antigens	in	lymphoma/lymphoproliferation
LMP1 Positive, focal expression Positive
EBNA2 Negative nd
EBER 30% reactivity nd
For each parameter the first value obtained is indicated. AMeasured 
after fresh frozen plasma transfusion. EA, early antigen; nd, not deter-
mined; EBER, EBV-encoded RNA.
Figure 1
Lymph node histology and NKT cells in patients 1 and 2. (A) Immuno-
histochemical staining of CD20 antigen in an axillary lymph node of 
patient 1 with hyperimmune reaction and medium-sized blast reacting 
with CD20. Hodgkin-like cells were not detected (alkaline phosphatase 
anti–alkaline-phosphatase reaction; hematoxilin). Original magnifica-
tion, ×200. (B) Immunohistochemical staining of CD20 antigen in an 
inguinal lymph node biopsy of patient 2 with positivity in Hodgkin- and 
Sternberg-Reed–like cells (avidin-biotin complex staining; hematoxi-
lin). Original magnification, ×100. (C) Staining of the same lymph node 
specimen from patient 1 with an intracellular polyclonal antibody gave 
only very weak signals. Original magnification, ×500. (D) In contrast, 
a strong ITK expression was observed in control lymph node tissue. 
Original magnification, ×500. (E and F) Measurement of NKT cells by 
FACS. After gating on CD3+ T cells, NKT cells were determined as 
TCR Vβ11 and TCR Vα24 double-positive cells. In patient 2 (E) NKT 
cells were virtually absent, whereas the percentage of NKT cells was 
0.35% in the healthy control subject (F).
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Table 2
Clinical and immunological characteristics
Category	 Parameter	 Patient	1	 Patient	2	 Reference	valuesA
Lymphocyte subsetsB,C Leukocytes, no./μl 8,700 3,100 5,200–11,000
 Lymphocytes, no./μl 3,480 732 2,300–5,400
 CD3+, % (no./μl) 32 (1,114) 74 (541) 56–75 (1,400–3,700)
 CD3+CD4+, % (no./μl) 14 (487) 58 (424) 28-47 (700–2,200)
 CD3+CD8+, % (no./μl) 14 (487) 12 (88) 16–30 (490–1,300)
 CD20+, % (no./μl) 60 (2,088) 0 2–76 (390–1,400)
 CD56+CD3–, % (no./μl) 8 (278) 5 (37) 4–17 (130–720)
 CD3+HLA-DR+, % 13 6 Not established
 TCRαβ+CD4–/CD8–, % nd 0.8 Not established
 TCRγδ+CD3+, % nd 4.6 Not established
 CD4+CD45RA+, % (no./μl) 33 (161) 5 (21) 53–86 (430–1,500)
 CD4+CD45RO+, % (no./μl) 77 (375) 94 (403) 9–26 (220–660)
 CD8+CD45RA+, % (no./μl) nd 54 (48) 69–97 (380–1,100)
 CD8+CD45RO+, % (no./μl) nd 46 (40) Not established
T cell function (cpm)D Medium 3,400 nd 600
  Mitogen stimulation PHA 67,600 nd 53,800
 PWM 21,200 nd 21,900
 OKT3 24,200 nd 66,200
 SAC 100 nd 10,000
  Antigen stimulation Medium 8,100 nd 800
 Tetanus toxoid 6,900 nd 1,100
 PPD 13,100 nd 4,100
 Candida 12,400 nd 1,300
TCR repertoireE  Diversified nd
NK cell function Intracellular perforin and granzyme  Normal Normal
  B expressionB
 NK cell lysisF Initially reduced,  nd
  normal during follow up
Serum immunoglobulins IgG (mg/dl) 355 816G 600–1,300
 IgA (mg/dl) 37 102G 60–220
 IgM (mg/dl) 28 90G 40–160
 IgE (IU/ml) nd <5
Specific antibodies Tetanus toxoid, diphtheria toxoid,  Present PresentG
  pneumococci, Hib
 Isohemagglutinins Present PresentG
Cytokines sCD25 (U/ml) nd 5,500
 IL-1β (pg/ml) nd <5
Exclusion of known  CD40 and CD40L expressionB Normal Normal
 immunodeficiencies SLAM (CD150), SAP, TNFRSF6, 2B4 (FasR) No mutation nd
Miscellaneous Fibrinogen (mg/dl) 432 281 180–350
 Ferritin (mg/dl) 186 7310 9–59
 Triglycerides (mg/dl) 432 370 11–127
 LDH (U/l) 682 748 <308
 Coombs test Negative Negative Negative
For each parameter, the first value obtained is indicated; unless otherwise denoted, this was before initiation of IVIG or immunomodulatory therapy.  
AUnless otherwise indicated, reference values are age-related laboratory normal values. For lymphocyte subsets, reference values are taken from Shearer 
et al. (38). Reference values for B cells refer to CD3–CD19+ cells. Reference values for T cell function refer to values measured from a control subject 
on the same day as patient 1. BObtained by FACS analysis. CIn patient 2, immunophenotyping of lymphocyte subsets was done after the start of therapy 
with dexamethasone and rituximab. D[3H]-thymidine incorporation was measured and expressed as the mean of triple measurements minus the medium 
values (values from cells in culture medium that were not stimulated with antigen or mitogen). EObtained by FACS analysis with monoclonal Vβ antibodies 
in patient 1. FNK cell–mediated lysis of [51Cr]-labeled K562 target cells. GObtained after fresh frozen plasma transfusion. PHA, phytohemagglutinin; PWM, 
pokeweed mitogen; OKT3, anti-CD3; SAC, Staphylococcus aureus Cowan I; PPD, purified protein derivative; Hib, Haemophilus influenzae type b; sCD25, 
soluble CD25; 2B4, natural killer cell receptor 2B4; LDH, lactate dehydrogenase.
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Figure 2
Identification of a homozygous missense mutation in ITK. (A) Pedigree of the affected sisters (individuals 3 and 4) with 2 consanguineous 
loops. Circles indicate females, squares indicate males. Individuals 1–8 were genotyped with a SNP array for linkage analysis. (B) lod score 
(ordinate) yielded by parametric linkage analysis with a recessive model. The maximum lod score of 2.15 was reached for 5 regions on chro-
mosomes 2, 5, 6, 8, and 17, with the largest region detected on chromosome 5q31–5q34. (C) Haplotype of individuals 1–4 on chromosome 
5q31–5q34. Reference SNP (rs) identification, genetic position (in cM), and genotype variant (1 or 2) are indicated for each SNP. “0” and a black 
line indicate an uninformative result for the particular marker. Both affected sisters showed a large homozygous region between rs2400642 
and rs17066124 containing the candidate gene ITK. To simplify the graphic representation, between rs10038913 (151.55 cM) and rs6860577 
(169.49 cM), 518 markers were skipped. (D) Relevant section of the 3′→5′ ITK sequencing data for individuals 1–4. Both affected siblings car-
ried a homozygous G→A single nucleotide mutation in exon 11 (ATA/CCA; 5′→3′, c.1,085 C→T). The father and mother were heterozygous 
(ATA/CCA/G). The affected position is marked with an arrow. The wild-type sequence is ATA/CCG (not shown). c.1,085 C→T leads to the 
amino acid substitution R335W.
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showed normal blood count, CRP, IgG and IgG subclasses, specific 
vaccination antibodies, hemagglutinins, and immunophenotyp-
ing of lymphocyte subsets. She was EBV VCA IgG positive and VCA 
IgM negative at that time. However, at the age of 16 months, the 
presence of maternal VCA IgG antibodies could not be excluded. 
At the age of 5 years, she developed recurrent episodes of fever and 
elevated CRP and erythrocyte sedimentation rate unresponsive to 
antibiotic treatment. Within 4 months the symptoms progressed 
to a life-threatening condition with profound pancytopenia, retro-
peritoneal and abdominal lymphadenopathy, hepatosplenomegaly, 
severely impaired liver function, ascites, and pleural effusion. At 
that time, aged 5 years 4 months, she was transferred to our hospi-
tal. PCR showed an active EBV infection with a virus load of 3,920 
copies/μg DNA in PB and 33,700 copies/μg in BM. EBV VCA IgG 
and anti-EBNA1 antibodies were positive, whereas VCA IgM anti-
bodies were absent. In isolated T and NK cells, no relevant EBV 
load could be detected (Table 1). The biopsy specimen of an ingui-
nal lymph node showed a proliferation of Hodgkin- and Sternberg-
Reed–like giant cells positive for CD20 (Figure 1B) and LMP1 and 
negative for CD30 and CD15. BM aspirate was normal. Further 
laboratory results are summarized in Table 2. Within the first day 
after admission to our hospital, the girl developed multiple organ 
failure requiring mechanical ventilation and hemodialysis for sev-
eral days. Treatment with ganciclovir, steroids, and rituximab at 
weekly intervals led to an improvement of symptoms and a stable 
virus load not exceeding 5,000 copies/μg DNA but did not induce 
a complete remission as initially seen in the sister. At the age of 
5 years 9 months, she received haploidentical PB stem cell trans-
plantation. During aplasia severe nasopharyngeal hemorrhage led 
to an acute airway obstruction with respiratory insufficiency and 
cardiovascular arrest. Unfortunately, she died 7 days after resusci-
tation from the consequences of ischemic brain injury. 
Molecular findings
Consanguinity of the parents and the similar clinical course in 
both daughters were suggestive for a genetic basis of the disease. 
We therefore initiated a genome-wide linkage analysis with 8 fam-
ily members including patient 1 (individual 3), patient 2 (indi-
vidual 4), father (individual 1), mother (individual 2), an aunt 
(individual 5), an uncle (individual 6), a male cousin (individual 7), 
and a female cousin (individual 8) (Figure 2A). Parametric linkage 
analysis with a recessive model revealed genome-wide 5 regions on 
chromosomes 2, 5, 6, 8, and 17 where the maximal possible lod 
score of 2.15 was reached (Figure 2B). The largest segment was on 
chromosome 5q31–5q34, where the homozygous region between 
recombinant markers rs2400642 and rs17066124 spanned 17.2 
Mb (Figure 2C). Within this region we identified 78 positional 
candidate genes including ITK, which appeared the most likely 
candidate for the development of the disease. Sequencing of ITK 
revealed the homozygous missense mutation C1085T in both 
affected individuals (Figure 2D). The parents, aunt, and male cous-
in (individuals 1, 2, 5, and 7) were identified as heterozygous car-
riers, whereas individuals 6 and 8 showed the wild-type sequence. 
To our knowledge, C1085T has not been published as a SNP, and 
the C1085T mutation was not present in 100 screened children of 
Turkish descent and 100 children of German descent (data not 
shown). Comparison of ITK sequences between different species 
revealed complete conservation of this residue from human to frog 
Xenopus (data not shown). The discovered mutation leads to the 
substitution of an arginine by tryptophan residue at position 335 
(R335W) in ITK. R335 is located in the BG loop of the ITK SH2 
domain (Figure 3C). Due to the distant location of the mutated 
residue to the phosphotyrosine binding pocket, it is not likely that 
this mutation impairs recruitment of the SH2 domain substrate. 
Attempts to functionally express the R335W mutant SH2 domain 
in bacteria failed due to aggregation of the recombinant protein 
testing 8 different expression constructs, whereas wild-type pro-
tein was stable and expressed functionally at high levels (data not 
shown). In silico prediction of protein stability revealed a severe 
destabilization of the SH2 domain by the mutation. We therefore 
expressed the R335W mutant and wild-type ITK along with differ-
ent controls in 293 T cells. By Western blot analysis, the R335W 
mutant protein was nearly undetectable (Figure 3A). To control 
that similar amounts of ITK mRNA were expressed in R335W and 
wild-type transfected cells, we performed quantitative RT-PCR 
after DNase digestion of the transfected plasmid. We found equal 
mRNA expression levels for R335W mutated and wild-type ITK 
(data not shown), which underlines the protein destabilizing effect 
of the R335W mutant. As a result of this protein instability, using 
a polyclonal ITK antibody, we found extremely low staining levels 
in the lymph node biopsy from patient 1 as compared with normal 
lymph node tissue (Figure 1, C and D).
Studies in Itk–/– mice suggest that ITK is required for repress-
ing the T box transcription factor eomesodermin (Eomes) in CD8+ 
single-positive T cells (24). In agreement with the low ITK levels 
detected in the biopsy, quantitative RT-PCR revealed a 1,000- to 
6,000-fold overexpression of Eomes in both affected children as 
compared with their heterozygous parents and 2 healthy male 
controls (Figure 3B). Finally, functional ITK has been shown to be 
essential for the development of NKT cells. After gating on CD3+ 
T cells, NKT cells were determined as TCR Vβ11 and TCR Vα24 
double-positive cells. In patient 2, NKT cells were virtually absent 
(Figure 1E), whereas the percentage of NKT cells in the healthy 
control subject shown in Figure 1F was 0.35%. Unfortunately we 
were not able to determine in retrospect the level of NKT cells in 
patient 1 due to the lack of appropriate material. However, the 
heterozygous parents showed a low percentage of NKT cells, which 
was 0.15% in the mother and 0.08% in the father, but both were 
healthy throughout their lives.
Discussion
We report what we believe is a novel primary immunodeficiency, 
which leads to an XLP-like phenotype in girls, caused by a homo-
zygous mutation in ITK on chromosome 5q31–5q32. This is the 
first molecular cause of an autosomal recessively inherited lym-
phoproliferative disease.
Both ITK-deficient individuals suffered from uncontrolled EBV 
infection meeting several criteria for secondary hemophagocytic 
lymphohistiocytosis, but without evidence of hemophagocytosis 
in BM and lymph nodes. In contrast to SAP deficiency, in which 
the development of preferably Burkitt lymphoma is not restricted 
to EBV-positive individuals, and XIAP deficiency, in which no case 
of lymphoma occurred so far, the leading symptom was an atypical, 
generalized EBV-positive B cell proliferation with progression to 
Hodgkin lymphoma in patient 1 (5, 14). It is not clear whether the 
progressive decline of lymphocytes in patient 1, which led to Pneu-
mocystis jirovecii and BK virus infection, was due to ITK deficiency 
itself, chronic EBV infection, or the long-lasting virostatic therapy.
The non-receptor tyrosine kinase ITK is a member of the Tec 
kinase family, which also includes Bruton’s tyrosine kinase (BTK), 
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Tec protein tyrosine kinase (TEC), RLK, and BM kinase X-linked 
(BMX) (15). Tec kinases contain a conserved SH3, SH2 and catalytic 
(kinase) domain. The SH2 domain of non-receptor tyrosine kinases 
is a non-catalytic protein interaction module, which by engaging 
with a phosphotyrosine-containing signaling partner regulates 
activity of the catalytic domain (16). Our results suggest that R335W 
mutant ITK causes a profound instability of the ITK protein rather 
than an impairment of ITK activation. Interestingly, mutations 
at exactly analogous positions within the SH2 domain have been 
described in BTK (Y361C) (17) and SAP (Q99P) (18), both leading 
Figure 3
Evidence of severe destabilization of the mutant ITK protein. (A) Western blot with transiently transfected 293 T cells using a monoclonal ITK 
antibody. Cyclophilin A was used as negative control (lane 1). No expression was detected for the R335W mutant (lane 5) and an ITK variant 
with complete deletion of the SH2 domain (lane 3), whereas wild-type ITK (lane 4) and the kinase-inactivating mutant (F511Y) (lane 2) showed 
strong ITK expression. (B) Results of quantitative real-time PCR for EOMES mRNA in CD8+ single-positive T cells on a logarithmic scale. We 
found 1,000- to 6,000-fold higher mRNA levels of EOMES in both affected children compared with their heterozygous parents or healthy controls. 
Error bars denote the standard deviation. P1, patient 1; P2, patient 2; F, father; M, mother; C1, control 1; C2, control 2. (C) Domain architecture of 
ITK and the location of the mutated residue (R335) (highlighted by a red label) in the SH2 domain. Shown is the NMR minimized average struc-
ture (protein data bank code 2etz). Protein instability probably results from a compromised salt bridge network (dotted lines) as well as surface 
exposure of the introduced tryptophan side chain. A phosphotyrosine substrate peptide and the corresponding binding pocket are located on the 
opposite side of the molecule. The main structural elements are labeled. (D) Site of the BG loop mutations in ITK (R335W, red), BTK (K374N, 
blue), and SAP (Q99P, yellow).
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to protein instability and the clinical phenotype of atypical X-linked 
agammaglobulinemia (XLA) and XLP, respectively (Figure 3D).
Given the pivotal role of ITK in a number of T cell signaling 
pathways, absence of Itk has been studied in great detail in mice, 
but no human disease with ITK deficiency has been described yet. 
The previously published experimental data in Itk–/– mouse cells 
greatly facilitated the choice of ITK among our candidate gene 
list of 78 genes after linkage analysis. Loss of Itk in mice leads to 
major immunological abnormalities, e.g., decreased responses to 
TCR stimulation, T cell proliferation, production of IL-2 and other 
effector cytokines, as well as altered thymic selection of CD4+ and 
CD8+ cells by modulation of TCR signal strength (19–23). In a set of 
elegant experiments, different research groups demonstrated that 
Tec kinase–deficient mice develop a large population of abnormal 
CD8+ T cells exhibiting innate immune properties but with high 
expression of the memory markers CD44 and CD122 (24–26).
We also found a clearly increased memory phenotype in our 
patients pointing to a profoundly altered differentiation of the 
conventional T cell lineage (Table 2). Perhaps the most impor-
tant paralleling feature between 
Itk-deficient mice and humans is 
the absence or reduced numbers 
of NKT cells. Itk–/– mice show a 
block of NKT cell maturation 
and reduced peripheral survival 
of NKT cells (8, 10, 11).
In mice, NKT cells have been 
shown to provide a protective 
innate-type immune response 
to several microbes (27) includ-
ing viruses, e.g., HSV1 and HSV2 
(28, 29) and hepatitis B virus (30). 
Strong evidence for a paramount 
biological relevance of NKT cells 
in humans comes from the obser-
vation that boys with XLP due to 
SAP or XIAP deficiency show a 
severely reduced number, or even 
a complete absence, of NKT cells 
(5, 6). Thus, a critical role for NKT 
cells in the immune response to 
EBV infection in humans has been 
postulated (5, 6). The absence of 
NKT cells in patient 2 and the 
concomitant inability to clear EBV 
infection in the 2 ITK-deficient 
sisters strengthens the hypothesis 
of a role for NKT cells in the con-
trol of EBV infection. The fact that 
both heterozygous parents have 
low but still detectable numbers of 
NKT cells also suggests that ITK is 
required for the selection and/or 
survival of NKT cells not only in 
mice, but also in humans. Rigaud 
et al. found normal numbers of 
NKT cells in 8 patients with acute 
infectious mononucleosis, show-
ing that the absence of NKT cells 
is not an immediate consequence 
of acute EBV infection (5), whereas to our knowledge there are no 
data on NKT cell numbers in patients with chronic active EBV 
infection. EBV affects more than 90% of the world’s population, 
but why the adequate immunological control of this successful 
member of the herpes family seems to be critically dependent on 
this numerically rather tiny cell population remains obscure.
However, as there are autoimmune conditions in which patients 
with a severely reduced number of NKT cells are not especially sus-
ceptible to EBV infection (31), the lack of NKT cells is likely to con-
tribute to the impaired immune response to EBV but may not be 
the single underlying factor. Other evidence for a protective role of 
invariant NKT cells in human infection is rather limited. In 2003 
Levy et al. reported a girl with severe varicella infection after vari-
cella vaccination, in whom an absolute deficiency of invariant NKT 
cells was the only detectable immunologic abnormality (32).
The immunophenotypical as well as functional analyses in our 
cases were performed following several months of active EBV 
infection. Thus, it is not possible to clearly distinguish between the 
impact of EBV infection and ITK deficiency itself. In the future, 
Table 3
5′→3′ primer sequences for nested amplification of the coding regions of ITK
Exon	 Primer	 Upstream	 Downstream
1 Ex GAAAGGATGTGGTTTCGGCCTTTG TTTCCTGTGCTCTATTTTATGCTATG
 In TCAGAGGAGAAGCTCAGCTATGTTGGC TTAGCCCAGTCCAAACATAAAATGC
2 Ex GCCAATGGATCTTATCTAGCAGTAG CTGCACCCGGCTGTGACTGAAG
 In ATATTGTCTTCTTTCTTACATGAATGG TTTTAACCACAGTCCAGGGAATGG
3 Ex CACTCTCGGCTCAGTAGGTCTG TCTCACACCACACTCTATTCTATTG
 In GTCAACTATCTCCATGCACGCTG AACCCTACTATAGGATCAAGAGTG
4 Ex GGCTCACTCAGCCAGGTCTAATC TGCATTCTGTTCCTGACACCCTC
 In GAGGTGTTATAAAATTGGTAGCCCT AATGATTAAAGGCCAAAAGCTTTTACT
5 Ex CAAGTCAGGTTTCACTGTGTCTTAT GACATGCAAATAGGAACATGCCAAT
 In CCCCTTTCTTCTGTTGTTTTCCTG GGTAGCCTGTGGGCCCACCTG
6 Ex CCAGAGGAAGGCAGACTGTCTC CTGTGGGAGATAGGACAAATCATC
 In CAGACACCCCGATGAAAGGAGG TCGCACCACACCTCAAACACGG
7 Ex ATATTCCCCAATCTTTAAATGACTTTTA AGTCAACCAATAATTTATTCCTAACTTA
 In TGGATTAAACCTATAAAATGATATAAAAC AGGATTCCTTAGGACTGTATTTTCC
8 Ex ATGACCATATGATTTTCTAGCATTGTC GCCTGCCAAATCGCTGGGATTC
 In TATAAGTAAATAATGAAACTTTAAAATATGT CAGTGCACTTAATTCATTTTATTTTATGT
9 Ex CCTACAGTATTTCCTCCTTCTGTG CTACCTCTTGCACTGTCTAACTTTG
 In GTGGAGCTGGAGGCATAAGCCT GCTCACACACTTCAGAAGTGTTTCT
10 Ex GTTATAAGACAAAGATAATAAGAACTTAA AGAAGGCAGAGCTCAGGCAGTAA
 In GTGTCTCAACATTGCTTCTTAATAATC TTGCTCACCTGCTGCTCACCTC
11 Ex TAGTGATTTAAGTTAGATGGTTGCTAG ATTTGTAGTCTGAGGAACAGGTAG
 In AGCAAAGCCCTAACCACTGCTTC ATTTGCCCCAGACCTTTAGGGAC
12 Ex GGCTAAAATTCTAGTTAGGGCTTTAT GCATTTCAAGAACACTGAACCGAT
 In TGGTATCCCAATACCTTATATCTACT CTGCATATCCTTGTTCTGAGCACT
13 Ex AGACAAAATGACCATTGGCTATTTTG AGATTATCTGTAATGTATTATTTATTAATG
 In TTGGGAGACTGAGTTTAGGCCATC CCAGTCATTTCAGTGAGAACTGTC
14/15A Ex TGCAGTAAAGCAAAGGACTGTGATT CAGGGTTCAGTGTGGGTAGGGTT
 In GAGACTCCTTAACTACTGATGACTC CAGCTGGCCTGAAGCCCAGATC
16 Ex AATCCTAATGCAAGGAGTCTGTAATT TGCCTCATCCTTCTGAGAGGGTT
 In TTGCTGTCTGTGGGCTTTGTCATT GGAAGGAGGGAGGTCCTCAAATT
17 Ex AATCCACAGGGGATGCTGCTATTA GCACCACATGTGACAAGAGGCTA
 In TGGATTTACCTATGACTCATAAGTAC AGCTCCCAGCTTGGTGGCTGAC
AThe short exons 14 and 15 were amplified together, including intron 14/15. Ex, external primers; In, inter-
nal primers.
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the identification and examination of further patients with ITK 
deficiency will certainly contribute to elucidating the functional 
implications of ITK deficiency in different lymphocyte lineages on 
host defense. We recommend that in all children with EBV-associ-
ated lymphoproliferative disorders, ITK deficiency should be con-
sidered because it may show striking clinical and immunological 
similarities to SAP or XIAP deficiency in boys.
Methods
The studies were reviewed and approved by the institutional review 
board (ethics committee) of Heinrich Heine University. The parents gave 
informed consent to carry out the investigations described below.
Linkage analysis. Samples were genotyped with the Affymetrix Human 
Mapping 250K Sty I array according to the manufacturer’s guidelines 
(Affymetrix). Genotype calling was performed with the Dynamic Model 
algorithm implemented in the Affymetrix software GTYPE version 4.1. The 
Call rate was above 94% for all samples; the average call rate was 97.15%.
Quality control and data conversion were managed by ALOHOMORA 
(http://gmc.mdc-berlin.de/alohomora/) (33). The correct relationship of 
individuals within the families was verified with the Graphical Representa-
tion of Relationships software (http://www.sph.umich.edu/csg/abecasis/
GRR/index.html) using 14,339 autosomal markers (34). Mendelian errors 
were detected by PedCheck (http://watson.hgen.pitt.edu/register/soft_doc.
html) and genotypes deleted in all individuals, while unlikely genotypes 
(double recombinants), identified with Merlin (http://www.sph.umich.
edu/csg/abecasis/Merlin/), were deleted in the individuals in which they 
appeared (35, 36). Parametric multipoint lod score analysis and haplotyp-
ing were performed using Merlin. We used a recessive model with com-
plete penetrance and a trait locus allele frequency of 0.0001. Marker allele 
frequencies for a European population as well as genetic positions were 
extracted from the Affymetrix SNP annotation file (version na23) (http://
www.affymetrix.com/support/technical/byproduct.affx?product=500k).
Of the 238,304 SNPs on the array, 238,230 had a physical and genetic 
position. To reduce the impact of linkage disequilibrium between closely 
linked markers on the lod score analysis, the pedigree was recalculated with 
smaller sets of markers (86,162 and 67,334 SNPs) with a minimal distance 
of 10,000 bp and minimal minor allele frequencies of 0.05 and 0.1. Graphi-
cal plots of the Merlin haplotypes were created using HaploPainter (http://
haplopainter.sourceforge.net) (37).
ITK staining in lymph node tissue. The polyclonal ITK antibody ab32113 
(Abcam) was used for staining of ITK in lymph node tissue.
ITK sequencing and expression of ITK constructs in 293T cells. Genomic DNA 
was extracted from PB leukocytes. Mutation analysis was performed by 
direct sequencing of PCR fragments obtained after nested amplification 
of the exonic and flanking intron region coding sequences of ITK with 17 
exons. Primers to amplify the genomic DNA samples were designed accord-
ing to GenBank sequences (Table 3). Direct cycle sequencing of all PCR 
fragments was performed with BigDye Terminator v3.1 cycle sequencing 
kit (Applied Biosystems) and analyzed by capillary electrophoresis on an 
ABI Prism 3130 Genetic Analyzer (Applied Biosystems). Analyzed sequences 
were compared with the cDNA and genomic DNA sequences in GenBank 
accession numbers NM_005546 (human ITK mRNA). The mutation 
nomenclature used follows the recommendation of the Human Genome 
Variation Society (http://www.hgvs.org/mutnomen).
Confluent 293T cells were transfected with either full-length mutated ITK 
or wild-type ITK plasmids, which were purchased from GenScript. Transient 
transfections were performed by polyethylenimine transfection using stan-
dard parameters, and Western blotting was performed 24 hours thereafter.
ITK Western blot. Postnuclear supernatant equivalents of 1 × 106 (or 0.5 × 106 
stimulated) cells were separated by 12% SDS-PAGE and blotted onto PVDF 
membranes (1 h, 100 V, Hybond-P; GE Healthcare) and blocked with 5% 
nonfat dry milk in PBS-Tween (0.05% Tween-20 in PBS) for 1 hour. After 
washing with PBS-Tween, the blots were incubated overnight with the pri-
mary antibody ITK 2F12 (catalog 2380; Cell Signaling Technology) at 4°C. 
Blots were washed again with PBS-Tween, incubated with the HRP-cou-
pled secondary antibodies (1:20,000) goat anti-rabbit (catalog RPN4301) 
and sheep anti-mouse IgG (catalog RPN4201V) horseradish peroxide 
(GE Healthcare) for 1 hour at room temperature, washed again, and then 
developed with a chemiluminescence reagent (Super Signal West Pico Che-
miluminescent Substrate; Thermo Scientific). Western blots were stripped 
with Re-Blot Plus (Millipore) and reprobed with ITK (Y402; catalog 1595-1; 
Epitomics) (for protocol, see above, beginning with blocking) to ensure the 
specificity of the antibody used first.
Quantitative real-time PCR analysis of Eomes expression. CD8+ T cells were 
isolated from PB using Miltenyi Biotec beads and columns. Total RNA 
was prepared from sorted cells using RNase Mini kit (Qiagen) and reverse 
transcribed into cDNA using Quantitect Reverse Transcription Kit (Qia-
gen) according to the manufacturer’s instructions. Quantitative PCR was 
performed using the primer and probe set for Eomes (Applied Biosystems), 
with S18 as a housekeeping gene. Data were analyzed using the ΔΔCT 
method and normalized to S18. The relative gene expression levels were 
then determined by comparing them with the expression found in the 
CD8+ population of the father, which were set as 1.
Immunophenotyping by flow cytometry. Whole blood was anticoagulated 
with EDTA and processed within 24 hours. A differential white blood cell 
count was done automatically. Four-color fluorescence-activated cell sort-
ing (FACS) analysis was performed with a FACS Calibur flow cytometer 
with CellQuest version 3.2 software (BD). Lymphocyte subpopulations 
were analyzed by FACS staining using FITC-, PE-, peridinin-chlorophyll 
protein– (PerCP-), and allophycocyanin-labeled monoclonal antibodies 
(BD or Immunotech) following the manufacturer’s instructions. Antibod-
ies (clone) against the following epitopes were used: CD3 (SK7; BD), CD4 
(SK3; BD), CD8 (SK1; BD), TCRab (WT31; BD), TCRgd (11F2; BD), TCR 
Vα24 (C15; Immunotech), TCR Vβ11 (C21; Immunotech), CD45RA (L48; 
BD), CD45RO (UCHL-1; BD), CD56 (MY31; BD), HLA-DR (L243; BD), 
and CD20 (L27; BD). Conserved thawed cells of both patients and healthy 
controls were CD3 positively selected using whole-blood CD3 MicroBeads 
(Miltenyi Biotec) following the manufacturer’s instructions. After gating on 
1 × 105 CD3+ T cell lymphocytes, the percentage of NKT cells (CD3+ TCR 
Vα24+ TCR Vβ11+) was determined by FACS.
Prediction of protein stability. For in silico prediction of protein stability, the 
Eris program was used (http://troll.med.unc.edu/eris).
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